Bank Of America Corp Nkarta, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Nkarta, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 115,009 shares of NKTX stock, worth $606,097. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,009

Previous 40,372 184.87%

Holding current value

$606,097

Previous $436,000 55.73%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.27 - $10.82 $393,336 - $807,572	74,637 Added 184.87%	115,009 $679,000
Q1 2024 May 15, 2024	SELL	$5.59 - $15.71 $457,111 - $1.28 Million	-81,773 Reduced 66.95%	40,372 $436,000
Q4 2023 Feb 14, 2024	BUY	$1.31 - $6.6 $51,519 - $259,564	39,328 Added 47.49%	122,145 $806,000
Q2 2023 Aug 14, 2023	SELL	$2.19 - $5.17 $95,764 - $226,073	-43,728 Reduced 34.56%	82,817 $181,000
Q1 2023 May 12, 2023	BUY	$3.37 - $6.3 $254,809 - $476,349	75,611 Added 148.45%	126,545 $449,000
Q4 2022 Feb 10, 2023	SELL	$5.14 - $14.35 $497,161 - $1.39 Million	-96,724 Reduced 65.51%	50,934 $305,000
Q3 2022 Nov 14, 2022	BUY	$12.27 - $18.39 $1.02 Million - $1.53 Million	82,993 Added 128.34%	147,658 $1.94 Million
Q2 2022 Aug 12, 2022	SELL	$7.77 - $19.44 $86,371 - $216,095	-11,116 Reduced 14.67%	64,665 $796,000
Q1 2022 May 16, 2022	BUY	$8.66 - $14.99 $142,794 - $247,170	16,489 Added 27.81%	75,781 $863,000
Q4 2021 Feb 08, 2022	BUY	$12.79 - $26.88 $217,660 - $457,443	17,018 Added 40.26%	59,292 $910,000
Q3 2021 Nov 15, 2021	SELL	$26.67 - $38.76 $140,577 - $204,303	-5,271 Reduced 11.09%	42,274 $1.18 Million
Q2 2021 Sep 13, 2021	BUY	$23.94 - $36.68 $1.14 Million - $1.74 Million	47,545 New	47,545 $1.51 Million

Others Institutions Holding NKTX

# of Institutions

120

Shares Held

66.2M

Call Options Held

142K

Put Options Held

43.1K

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $256M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Nkarta, Inc. Transaction History